These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 28063083

  • 1. Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland-Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data.
    Madan J, Khan KA, Petrou S, Lamb SE.
    Pharmacoeconomics; 2017 May; 35(5):549-559. PubMed ID: 28063083
    [Abstract] [Full Text] [Related]

  • 2. Mapping between the Roland Morris Questionnaire and generic preference-based measures.
    Khan KA, Madan J, Petrou S, Lamb SE.
    Value Health; 2014 Sep; 17(6):686-95. PubMed ID: 25236992
    [Abstract] [Full Text] [Related]

  • 3. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
    Gray LA, Wailoo AJ, Hernandez Alava M.
    Value Health; 2018 Dec; 21(12):1399-1405. PubMed ID: 30502783
    [Abstract] [Full Text] [Related]

  • 4. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ, Thompson AJ, Turner AJ, Longworth L, McElhone K, Griffiths CEM, Payne K, BADBIR Study Group.
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
    Franken MD, de Hond A, Degeling K, Punt CJA, Koopman M, Uyl-de Groot CA, Versteegh MM, van Oijen MGH.
    Health Qual Life Outcomes; 2020 Jul 20; 18(1):240. PubMed ID: 32690011
    [Abstract] [Full Text] [Related]

  • 6. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
    Marriott ER, van Hazel G, Gibbs P, Hatswell AJ.
    J Med Econ; 2017 Feb 20; 20(2):193-199. PubMed ID: 27676291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correlation between pain, disability, and quality of life in patients with common low back pain.
    Kovacs FM, Abraira V, Zamora J, Teresa Gil del Real M, Llobera J, Fernández C, Bauza JR, Bauza K, Coll J, Cuadri M, Duro E, Gili J, Gestoso M, Gómez M, González J, Ibañez P, Jover A, Lázaro P, Llinás M, Mateu C, Mufraggi N, Muriel A, Nicolau C, Olivera MA, Pascual P, Perelló L, Pozo F, Revuelta T, Reyes V, Ribot S, Ripoll J, Ripoll J, Rodríguez E, Kovacs-Atención Primaria Group.
    Spine (Phila Pa 1976); 2004 Jan 15; 29(2):206-10. PubMed ID: 14722416
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L.
    Lindkvist M, Feldman I.
    Health Qual Life Outcomes; 2016 Sep 20; 14(1):134. PubMed ID: 27644119
    [Abstract] [Full Text] [Related]

  • 13. A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
    Shaw JW, Bennett B, Trigg A, DeRosa M, Taylor F, Kiff C, Ntais D, Noon K, King MT, Cocks K.
    Value Health; 2021 Nov 20; 24(11):1651-1659. PubMed ID: 34711366
    [Abstract] [Full Text] [Related]

  • 14. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
    Moore A, Young CA, Hughes DA.
    Value Health; 2018 Nov 20; 21(11):1322-1329. PubMed ID: 30442280
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Can EQ-5D-3L utility values of low back pain patients be validly predicted by the Oswestry Disability Index for use in cost-effectiveness analyses?
    Pellekooren S, Ben ÂJ, Bosmans JE, Ostelo RWJG, van Tulder MW, Maas ET, Huygen FJPM, Oosterhuis T, Apeldoorn AT, van Hooff ML, van Dongen JM.
    Qual Life Res; 2022 Jul 20; 31(7):2153-2165. PubMed ID: 35040002
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Validation of the European Quality of Life-5 Dimensions, 3-Level Version (EQ-5D-3L) in Patients With Osteoporotic Vertebral Fracture and Comparing Their Health-Related Quality of Life With That of the General Population in Korea.
    Jeong JH, Jo MW, Chin DK, Son WS, Ock M, Lee JK.
    Korean J Neurotrauma; 2022 Apr 20; 18(1):64-74. PubMed ID: 35557648
    [Abstract] [Full Text] [Related]

  • 20. Mapping the EORTC-QLQ-C30 to the EQ-5D-3L: An Assessment of Existing and Newly Developed Algorithms.
    Woodcock F, Doble B, CANCER 2015 Consortium.
    Med Decis Making; 2018 Nov 20; 38(8):954-967. PubMed ID: 30226101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.